VR-MELODY - Utilising music and AI to advance DR.VR™ and co-create a personalised VR solution to reduce anxiety and build mental resilience in adults

Rescape已经提供沉浸式治疗超过3年。它已经授权并部署了我们的疼痛和焦虑产品DR.VR（tm），在50多个医疗环境中拥有超过100个VR头盔许可证。该软件属于1类医疗器械。该系统旨在解决问题，我们与卡迪夫大学（Cardiff University）制定了严格的新冠病毒净化协议。经过一段试用期后，我们于2022年正式推出沉浸式治疗解决方案，帮助NHS员工管理压力，焦虑和倦怠。该产品正在医院中发挥作用，利用心理学家Smalley博士1开发的8部分放松课程。我们的下一个发展阶段是推进我们的平台，具有临床严谨性，使一个特定的心理健康产品提供给更广泛和多样化的观众。这个项目的目的是探索如何音乐内容和人工智能（AI）可用于推进DR.VR（tm）的当前沉浸式治疗内容并为经历焦虑症状的人创建个性化的VR解决方案，并建立心理弹性。我们很高兴这笔资金将如何通过使用沉浸式和新兴技术。

Rescape have been delivering immersive therapies for over 3 years. It has licenced and deployed DR.VR(tm) our pain and anxiety product, with over 100+ VR headset licences into 50+ healthcare environments. The software is a class 1 medical device. The system is designed to work out the box and we have created a rigorous covid decontamination protocol with Cardiff University.In 2022 after a trial period, we formally launched an immersive therapy solution, helping NHS staff manage stress, anxiety and burn out. This product is making impact in hospitals utilising an 8-part relaxation course developed with Psychologist Dr Smalley1\.Our next stage of development is to advance our platform, with clinical rigour, to make a specific mental health product available to a wider and diverse audience.The aim of this project is to explore how music content and Artificial Intelligence (AI) can be utilised to advance current immersive therapeutic content from DR.VR(tm) and create a personalised VR solution for people experiencing symptoms of anxiety and build mental resilience.We are excited how this funding will help further patient benefits and outcomes through the use of immersive and emerging technologies.